p. 1-6Background: Outbreaks of orally transmitted Trypanosoma cruzi continue to be reported in Brazil and are associated with a high mortality rate, mainly due to myocarditis. Methods: This study is a detailed report on the disease progression of acute Chagas disease in 13 patients who were infected during two micro-outbreaks in two northeastern Brazilian towns. Clinical outcomes as well as EKG and ECHO results are described, both before and after benznidazole treatment. Results: Fever and dyspnea were the most frequent symptoms observed. Other clinical findings included myalgia, periorbital edema, headache and systolic murmur. Two patients died of cardiac failure before receiving benznidazole treatment. EKG and ECHO findings frequently sho...
Abstract: INTRODUCTION: Chagas disease currently affects 5.7 million people in Latin America and is...
Chagas disease is a type of parasitosis caused by the protozoan Trypanosoma cruzi, and it is transmi...
INTRODUCTION Chagas disease is a major public health problem that is endemic in Brazil and Latin Am...
BACKGROUND: Outbreaks of orally transmitted Trypanosoma cruzi continue to be reported in Brazil and ...
continue to be reported in Brazil and are associated with a high mortality rate, mainly due to myoc...
Four cases of serious cardiac attacks by autochthonous Trypanosoma cruzi infection from the Brazilia...
Chagas cardiomyopathy is the most frequent and most severe manifestation of chronic Chagas disease, ...
Abstract Background: In the past two decades, a new epidemiological profile of Chagas’ disease (CD)...
<p>Patient #6 and 7 died before evaluation.</p>¥<p>performed 180 days after the end of benzonidazol ...
The objective of this report is to describe treatment outcomes over a four-year period of patients w...
Chagas disease caused by the protozoan Trypanosoma cruzi is the leading cause of heart disease in La...
In Mexico, despite the relatively high seroprevalence of Trypanosoma cruzi infection in humans in so...
Chagas disease is caused by the parasite Trypanosoma cruzi, and mostly aff ects poor rural populatio...
Background Benznidazole is effective for treating acute and chronic (recently acquired) Tryponosoma ...
Chagas? disease (ChD), caused by the protozoa Trypanosoma cruzi (T. cruzi), was discovered and descr...
Abstract: INTRODUCTION: Chagas disease currently affects 5.7 million people in Latin America and is...
Chagas disease is a type of parasitosis caused by the protozoan Trypanosoma cruzi, and it is transmi...
INTRODUCTION Chagas disease is a major public health problem that is endemic in Brazil and Latin Am...
BACKGROUND: Outbreaks of orally transmitted Trypanosoma cruzi continue to be reported in Brazil and ...
continue to be reported in Brazil and are associated with a high mortality rate, mainly due to myoc...
Four cases of serious cardiac attacks by autochthonous Trypanosoma cruzi infection from the Brazilia...
Chagas cardiomyopathy is the most frequent and most severe manifestation of chronic Chagas disease, ...
Abstract Background: In the past two decades, a new epidemiological profile of Chagas’ disease (CD)...
<p>Patient #6 and 7 died before evaluation.</p>¥<p>performed 180 days after the end of benzonidazol ...
The objective of this report is to describe treatment outcomes over a four-year period of patients w...
Chagas disease caused by the protozoan Trypanosoma cruzi is the leading cause of heart disease in La...
In Mexico, despite the relatively high seroprevalence of Trypanosoma cruzi infection in humans in so...
Chagas disease is caused by the parasite Trypanosoma cruzi, and mostly aff ects poor rural populatio...
Background Benznidazole is effective for treating acute and chronic (recently acquired) Tryponosoma ...
Chagas? disease (ChD), caused by the protozoa Trypanosoma cruzi (T. cruzi), was discovered and descr...
Abstract: INTRODUCTION: Chagas disease currently affects 5.7 million people in Latin America and is...
Chagas disease is a type of parasitosis caused by the protozoan Trypanosoma cruzi, and it is transmi...
INTRODUCTION Chagas disease is a major public health problem that is endemic in Brazil and Latin Am...